Optimizing The Development And Upscaling Of API / HPAPI And Fermentation Projects
Source: Evonik Corporation
Pharmaceutical and biopharmaceutical projects for the development and upscaling of APIs, HPAPIs and intermediates continue to increase in process complexity. In this interview, Dr. Ingo Klement, Director, Global Business Development for Exclusive Synthesis at Evonik, shares some of the key expectations of customers who are reviewing CMOs to support the development and upscaling of their next major project.
access the Q&A!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.
Subscribe to Pharmaceutical Online
X
Subscribe to Pharmaceutical Online
Evonik Corporation
This website uses cookies to ensure you get the best experience on our website. Learn more